ICUD-EAU international consultation on bladder cancer 2012: Pathology

European Urology

Volumn 63, Issue 1, 2013, Pages 16-35

  Amin, Mahul B ^a   McKenney, Jesse K ^b   Paner, Gladell P ^c   Hansel, Donna E ^b   Grignon, David J ^d   Montironi, Rodolfo ^e   Lin, Oscar ^f   Jorda, Merce ^g   Jenkins, Lawrence C ^g   Soloway, Mark ^g   Epstein, Jonathan I ^h   Reuter, Victor E ^f  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Bladder cancer; Immunohistochemistry; Markers; Pathology; Recommendations; Staging

Indexed keywords

ADIPOSE TISSUE; BLADDER BIOPSY; BLADDER CANCER; CANCER GENETICS; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CHEMORADIOTHERAPY; CHROMOSOME ABERRATION; CLEAR CELL CARCINOMA; CYSTECTOMY; DYSPLASIA; EVIDENCE BASED MEDICINE; GIANT CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; LOW LEVEL LASER THERAPY; LYMPHOEPITHELIOMA; NOMENCLATURE; PAPILLARY CARCINOMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; SARCOMATOID CARCINOMA; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; SYSTEMATIC REVIEW; TRANSITIONAL CELL CARCINOMA; TROPHOBLASTIC TUMOR; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA; URACHAL ADENOCARCINOMA; URINE CYTOLOGY; VERRUCOUS CARCINOMA;

BIOPSY; CARCINOMA; COOPERATIVE BEHAVIOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERDISCIPLINARY COMMUNICATION; NEOPLASM STAGING; PATHOLOGY, CLINICAL; PATHOLOGY, MOLECULAR; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84870478491     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.09.063     Document Type: Review

References (124)

1. Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - levels of evidence (March 2009). Centre for Evidence-based Medicine Web site. http://www.cebm.net/index.aspx?o=1025.
2. D.C. Taylor, B.S. Bhagavan, M.P. Larsen, J.A. Cox, and J.I. Epstein Papillary urothelial hyperplasia. A precursor to papillary neoplasms Am J Surg Pathol 20 1996 1481 1488
3. E.D. Long, and R.T. Shepherd The incidence and significance of vaginal metaplasia of the bladder trigone in adult women Br J Urol 55 1983 189 194
4. I. Ozbey, Y. Aksoy, O. Polat, O. Bicgi, and A. Demirel Squamous metaplasia of the bladder: findings in 14 patients and review of the literature Int Urol Nephrol 31 1999 457 461
5. C.C. Guo, S.W. Fine, and J.I. Epstein Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases Am J Surg Pathol 30 2006 883 891
6. P.S. Bullock, D.E. Thoni, and W.M. Murphy The significance of colonic mucosa (intestinal metaplasia) involving the urinary tract Cancer 59 1987 2086 2090
7. J.I. Lin, H.S. Yong, C.H. Tseng, P.S. Marsidi, C. Choy, and B. Pilloff Diffuse cystitis glandularis. Associated with adenocarcinomatous change Urology 15 1980 411 415
8. F.A. Corica, D.A. Husmann, and B.M. Churchill Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up Urology 50 1997 427 431
9. A.K. Smith, D.E. Hansel, and J.S. Jones Role of cystitis cystica et glandularis and intestinal metaplasia in development of bladder carcinoma Urology 71 2008 915 918
10. A. Lopez-Beltran, R.J. Luque, R. Mazzucchelli, M. Scarpelli, and R. Montironi Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer J Clin Pathol 55 2002 641 647
11. S.S. Shen, C.C. Guo, and J.Y. Ro Common problems in interpretation of early invasive bladder cancer: a consensus study Mod Pathol 24 2011 224A
12. I. Tosoni, U. Wagner, and G. Sauter Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer BJU Int 85 2000 48 53
13. A. Orsola, I. Trias, and C.X. Raventos Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients Eur Urol 48 2005 231 238 discussion 238
14. G. Smits, E. Schaafsma, L. Kiemeney, C. Caris, F. Debruyne, and J.A. Witjes Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression Urology 52 1998 1009 1013 discussion 1013-4
15. M. Younes, J. Sussman, and L.D. True The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder Cancer 66 1990 543 548
16. G.P. Paner, J.Y. Ro, E.M. Wojcik, G. Venkataraman, M.W. Datta, and M.B. Amin Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma Am J Surg Pathol 31 2007 1420 1429
17. A. Aydin, R. Ucak, M. Karakok, M.E. Guldur, and N.E. Kocer Vascular plexus is a differentiation criterion for muscularis mucosa from muscularis propria in small biopsies and transurethral resection materials of urinary bladder? Int Urol Nephrol 34 2002 315 319
18. H. Miyamoto, and J.I. Epstein Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria Urology 76 2010 600 602
19. H. Tokgoz, K. Turkolmez, B. Resorlu, K. Kose, O. Tulunay, and Y. Beduk Pathological staging of muscle invasive bladder cancer. is substaging of pT2 tumors really necessary? Int Braz J Urol 33 2007 777 783 discussion 783-4
20. R.J. Yu, J.P. Stein, J. Cai, G. Miranda, S. Groshen, and D.G. Skinner Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy J Urol 176 2006 493 498 discussion 498-9
21. G. Sonpavde, M.M. Khan, and R.S. Svatek Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy BJU Int 108 2011 687 692
22. D. Tilki, O. Reich, and P.I. Karakiewicz Validation of the AJCC TNM substaging of pT2 bladder cancer: deep muscle invasion is associated with significantly worse outcome Eur Urol 58 2010 112 117
23. A.T. Philip, M.B. Amin, P. Tamboli, T.J. Lee, C.E. Hill, and J.Y. Ro Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis Am J Surg Pathol 24 2000 1286 1290
24. P.J. Bastian, G.C. Hutterer, and S.F. Shariat Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival BJU Int 101 2008 450 454
25. K.J. Boudreaux Jr., S.S. Chang, and W.T. Lowrance Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes Cancer 115 2009 770 775
26. M.L. Quek, J.P. Stein, and P.E. Clark Microscopic and gross extravesical extension in pathological staging of bladder cancer J Urol 171 2004 640 645
27. M.L. Quek, J.P. Stein, and P.E. Clark Natural history of surgically treated bladder carcinoma with extravesical tumor extension Cancer 98 2003 955 961
28. E. Scosyrev, J. Yao, and E. Messing Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice Urology 76 2010 908 913 discussion 914
29. D. Tilki, R.S. Svatek, and P.I. Karakiewicz pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder J Urol 184 2010 470 474
30. R. Montironi, R. Mazzucchelli, M. Scarpelli, A. Lopez-Beltran, and L. Cheng Morphological diagnosis of urothelial neoplasms J Clin Pathol 61 2008 3 10
31. M. Birkhahn, A.P. Mitra, and A.J. Williams Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles Eur Urol 57 2010 12 20
32. M. May, S. Brookman-Amissah, and J. Roigas Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications Eur Urol 57 2010 850 858
33. B.W. van Rhijn, M. Burger, and Y. Lotan Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur Urol 56 2009 430 442
34. L. Cheng, M. Darson, and J.C. Cheville Urothelial papilloma of the bladder. Clinical and biologic implications Cancer 86 1999 2098 2101
35. C. Magi-Galluzzi, and J.I. Epstein Urothelial papilloma of the bladder: a review of 34 de novo cases Am J Surg Pathol 28 2004 1615 1620
36. J.K. McKenney, M.B. Amin, and R.H. Young Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases Mod Pathol 16 2003 623 629
37. W.M. Murphy, K. Takezawa, and N.A. Maruniak Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care J Urol 168 2002 968 972
38. R. Montironi, A. Lopez-Beltran, M. Scarpelli, R. Mazzucchelli, and L. Cheng Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder Histopathology 53 2008 621 633
39. G. Dalbagni, K. Vora, and M. Kaag Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer Eur Urol 56 2009 903 910
40. R.T. Divrik, A.F. Sahin, U. Yildirim, M. Altok, and F. Zorlu Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial Eur Urol 58 2010 185 190
41. H.M. Fritsche, M. Burger, and R.S. Svatek Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort Eur Urol 57 2010 300 309
42. G.S. Kulkarni, O.W. Hakenberg, and J.E. Gschwend An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer Eur Urol 57 2010 60 70
43. B.W.G. van Rhijn, T.C.M. Zuiverloon, and A.N. Vis Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer Eur Urol 58 2010 433 441
44. M.B. Amin Histological variants of urothelial carcinoma: diagnostic, therapeutic and prognostic implications Mod Pathol 22 Suppl 2 2009 S96 S118
45. J.I. Epstein, V.E. Reuter, and M.B. Amin Biopsy interpretation of the bladder ed. 2. 2010 Lippincott Williams and Wilkins Philadelphia, PA
46. A. Lopez-Beltran, M.J. Requena, L. Cheng, and R. Montironi Pathological variants of invasive bladder cancer according to their suggested clinical significance BJU Int 101 2008 275 281
47. M.B. Amin, J.Y. Ro, and T. el-Sharkawy Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma Am J Surg Pathol 18 1994 1224 1232
48. J.M. Gaya, J. Palou, F. Algaba, J. Arce, O. Rodriguez-Faba, and H. Villavicencio The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ Can J Urol 17 2010 5370 5376
49. A.M. Kamat, C.P. Dinney, and J.R. Gee Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients Cancer 110 2007 62 67
50. C.G. Rogers, G.S. Palapattu, and S.F. Shariat Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder J Urol 175 2006 2048 2053 discussion 2053
51. N. Nese, A.R. Kandiloglu, and Y.Z. Atesci Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports Int J Urol 14 2007 365 367
52. Q.J. Zhai, J. Black, A.G. Ayala, and J.Y. Ro Histologic variants of infiltrating urothelial carcinoma Arch Pathol Lab Med 131 2007 1244 1256
53. F. Liedberg, G. Chebil, T. Davidsson, V. Gadaleanu, M. Grabe, and W. Mansson The nested variant of urothelial carcinoma: a rare but important bladder neoplasm with aggressive behavior. Three case reports and a review of the literature Urol Oncol 21 2003 7 9
54. A. Lopez-Beltran, A. Pacelli, and H.J. Rothenberg Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases J Urol 159 1998 1497 1503
55. L. Perret, P. Chaubert, D. Hessler, and L. Guillou Primary heterologous carcinosarcoma (metaplastic carcinoma) of the urinary bladder: a clinicopathologic, immunohistochemical, and ultrastructural analysis of eight cases and a review of the literature Cancer 82 1998 1535 1549
56. S. Dirnhofer, P. Koessler, C. Ensinger, H. Feichtinger, S. Madersbacher, and P. Berger Production of trophoblastic hormones by transitional cell carcinoma of the bladder: association to tumor stage and grade Hum Pathol 29 1998 377 382
57. R.K. Iles, and T. Chard Human chorionic gonadotropin expression by bladder cancers: biology and clinical potential J Urol 145 1991 453 458
58. K. Sievert, E.A. Weber, R. Herwig, H. Schmid, S. Roos, and H.U. Eickenberg Pure primary choriocarcinoma of the urinary bladder with long-term survival Urology 56 2000 856
59. E. Domanowska, W. Jozwicki, and J. Domaniewski Muscle-invasive urothelial cell carcinoma of the human bladder: multidirectional differentiation and ability to metastasize Hum Pathol 38 2007 741 746
60. A. Lopez-Beltran, A. Blanca, R. Montironi, L. Cheng, and J.C. Regueiro Pleomorphic giant cell carcinoma of the urinary bladder Hum Pathol 40 2009 1461 1466
61. A. Lopez-Beltran, L. Cheng, and E. Comperat Large cell undifferentiated carcinoma of the urinary bladder Pathology 42 2010 364 368
62. D. Baydar, M.B. Amin, and J.I. Epstein Osteoclast-rich undifferentiated carcinomas of the urinary tract Mod Pathol 19 2006 161 171
63. J.N. Eble, G. Sauter, and J.I. Epstein Pathology and genetics of tumors of the urinary system and male genital organs 2004 IARC Press Lyon, France
64. N. Lagwinski, A. Thomas, and A.J. Stephenson Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases Am J Surg Pathol 31 2007 1777 1787
65. D.A. Swanson, A. Liles, and G.K. Zagars Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder J Urol 143 1990 37 40
66. M.N. El-Bolkainy, N.M. Mokhtar, M.A. Ghoneim, and M.H. Hussein The impact of schistosomiasis on the pathology of bladder carcinoma Cancer 48 1981 2643 2648
67. M.R. Mahran, and M. el-Baz Verrucous carcinoma of the bilharzial bladder. Impact of invasiveness on survival Scand J Urol Nephrol 27 1993 189 192
68. A.G. Batta, D.E. Engen, H.M. Reiman, and R.K. Winkelmann Intravesical condyloma acuminatum with progression to verrucous carcinoma Urology 36 1990 457 464
69. P.I. Ellsworth, A.R. Schned, J.A. Heaney, and P.M. Snyder Surgical treatment of verrucous carcinoma of the bladder unassociated with bilharzial cystitis: case report and literature review J Urol 153 1995 411 414
70. S.A. Horner, H.A. Fisher, J.H. Barada, A.Y. Eastman, J. Migliozzi, and J.S. Ross Verrucous carcinoma of the bladder J Urol 145 1991 1261 1263
71. C. Anderstrom, S.L. Johansson, and L. von Schultz Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study Cancer 52 1983 1273 1280
72. D.J. Grignon, J.Y. Ro, A.G. Ayala, D.E. Johnson, and N.G. Ordonez Primary adenocarcinoma of the urinary bladder. A clinicopathologic analysis of 72 cases Cancer 67 1991 2165 2172
73. M.L. Blute, D.E. Engen, W.D. Travis, and L.K. Kvols Primary signet ring cell adenocarcinoma of the bladder J Urol 141 1989 17 21
74. D.J. Grignon, J.Y. Ro, A.G. Ayala, and D.E. Johnson Primary signet-ring cell carcinoma of the urinary bladder Am J Clin Pathol 95 1991 13 20
75. O. Burgues, J. Ferrer, S. Navarro, D. Ramos, E. Botella, and A. Llombart-Bosch Hepatoid adenocarcinoma of the urinary bladder. An unusual neoplasm Virchows Arch 435 1999 71 75
76. J.L. Wright, P.C. Black, and G.A. Brown Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder J Urol 178 2007 2302 2306 discussion 2307
77. J.N. Eble Abnormalities of the urachus 1989 Churchill-Livingstone New York, NY
78. M. Ghazizadeh, S. Yamamoto, and K. Kurokawa Clinical features of urachal carcinoma in Japan: review of 157 patients Urol Res 11 1983 235 238
79. E.D. Whitehead, and A.N. Tessler Carcinoma of the urachus Br J Urol 43 1971 468 476
80. P.J. Chor, L.D. Gaum, and R.H. Young Clear cell adenocarcinoma of the urinary bladder: report of a case of probable müllerian origin Mod Pathol 6 1993 225 228
81. E. Oliva, M.B. Amin, R. Jimenez, and R.H. Young Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems Am J Surg Pathol 26 2002 190 197
82. F. Vakar-Lopez, and L.D. True How wide is the spectrum of neuroendocrine carcinoma of the urinary bladder? Am J Clin Pathol 128 2007 723 725
83. S. Thompson, M. Cioffi-Lavina, J. Chapman-Fredricks, C. Gomez-Fernandez, G. Fernandez-Castro, and M. Jorda Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach Appl Immunohistochem Mol Morphol 19 2011 395 399
84. A. Bex, J.A. Nieuwenhuijzen, and M. Kerst Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer Urology 65 2005 295 299
85. L. Cheng, C.X. Pan, and X.J. Yang Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients Cancer 101 2004 957 962
86. X. Wang, G.T. MacLennan, A. Lopez-Beltran, and L. Cheng Small cell carcinoma of the urinary bladder - histogenesis, genetics, diagnosis, biomarkers, treatment, and prognosis Appl Immunohistochem Mol Morphol 15 2007 8 18
87. H.E. Schaafsma, F.C. Ramaekers, and G.N. van Muijen Distribution of cytokeratin polypeptides in human transitional cell carcinomas, with special emphasis on changing expression patterns during tumor progression Am J Pathol 136 1990 329 343
88. F. Brimo, R.T. Vollmer, B. Case, A. Aprikian, W. Kassouf, and M. Auger Accuracy of urine cytology and the significance of an atypical category Am J Clin Pathol 132 2009 785 793
89. L. Bubendorf Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch Acta Cytol 55 2011 113 119
90. A.A. Renshaw Subclassifying atypical urinary cytology specimens Cancer 90 2000 222 229
91. N.P. Caraway, and R.L. Katz A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis Cancer Cytopathol 118 2010 175 183
92. M.A. Hudson, and H.W. Herr Carcinoma in situ of the bladder J Urol 153 1995 564 572
93. H.G. Wiener, C. Mian, A. Haitel, A. Pycha, G. Schatzl, and M. Marberger Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 159 1998 1876 1880
94. K.C. Halling, W. King, and I.A. Sokolova A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J Urol 164 2000 1768 1775
95. F.S. Krause, A. Rauch, K.M. Schrott, and D.G. Engehausen Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? World J Urol 24 2006 418 422
96. J. Laudadio, T.E. Keane, and H.M. Reeves Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice BJU Int 96 2005 1280 1285
97. M. Lodde, C. Mian, and E. Comploj uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma Urology 67 2006 950 954
98. C. Mian, M. Lodde, and E. Comploj Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer J Clin Pathol 59 2006 984 987
99. P.M.J. Moonen, G.F.M. Merkx, P. Peelen, H.F.M. Karthaus, D.F.C.M. Smeets, and J.A. Witjes UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer Eur Urol 51 2007 1275 1280 discussion 1280
100. M.F. Sarosdy, P.R. Kahn, and M.D. Ziffer Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria J Urol 176 2006 44 47
101. G.L. Schroeder, M.F. Lorenzo-Gomez, and S.H. Hautmann A side by side comparison of cytology and biomarkers for bladder cancer detection J Urol 172 2004 1123 1126
102. Y. Sun, D.L. He, and Q. Ma Comparison of seven screening methods in the diagnosis of bladder cancer Chin Med J (Engl) 119 2006 1763 1771
103. B. Tetu, R. Tiguert, F. Harel, and Y. Fradet ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma Mod Pathol 18 2005 83 89
104. M.I. Toma, M.G. Friedrich, and S.H. Hautmann Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer World J Urol 22 2004 145 149
105. S. Bastacky, S. Ibrahim, S.P. Wilczynski, and W.M. Murphy The accuracy of urinary cytology in daily practice Cancer 87 1999 118 128
106. M.F. Sarosdy, P. Schellhammer, and G. Bokinsky Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer J Urol 168 2002 1950 1954
107. T. Hajdinjak UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing Urol Oncol 26 2008 646 651
108. K.C. Halling, and B.R. Kipp Bladder cancer detection using FISH (UroVysion assay) Adv Anat Pathol 15 2008 279 286
109. B.R. Kipp, M. Tanasescu, and T.A. Else Quantitative fluorescence in situ hybridization and its ability to predict bladder cancer recurrence and progression to muscle-invasive bladder cancer J Mol Diagn 11 2009 148 154
110. S. Savic, I. Zlobec, and G.N. Thalmann The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy Int J Cancer 124 2009 2899 2904
111. B.J. Schlomer, R. Ho, A. Sagalowsky, R. Ashfaq, and Y. Lotan Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder J Urol 183 2010 62 67
112. H.M. Fritsche, M. Burger, and W. Dietmaier Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder Am J Clin Pathol 134 2010 597 603
113. L. Mengual, M. Marin-Aguilera, and M.J. Ribal Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy Eur Urol 52 2007 752 759
114. J. Whitson, A. Berry, P. Carroll, and B. Konety A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy BJU Int 104 2009 336 339
115. S. Gudjónsson, B.L. Isfoss, and K. Hansson The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer Eur Urol 54 2008 402 408
116. T. Zellweger, G. Benz, and G. Cathomas Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer Int J Cancer 119 2006 1660 1665
117. A. Karnwal, R. Venegas, B. Shuch, J. Bassett, J. Rajfer, and R. Reznichek The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer Can J Urol 17 2010 5077 5081
118. R.F. Youssef, B.J. Schlomer, R. Ho, A.I. Sagalowsky, R. Ashfaq, and Y. Lotan Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology Urol Oncol 30 2012 273 277
119. E.M. Wojcik, R.J. Brownlie, T.J. Bassler, and M.C. Miller Superficial urothelial (umbrella) cells. A potential cause of abnormal DNA ploidy results in urine specimens Anal Quant Cytol Histol 22 2000 411 415
120. K. Chrouser, B. Leibovich, E. Bergstralh, H. Zincke, and M. Blute Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer J Urol 174 2005 107 110 discussion 110-1
121. W.M. Murphy What's the trouble with cytology? J Urol 176 2006 2343 2346
122. A.M. Nieder, M.S. Soloway, and H.W. Herr Should we abandon the FISH test? Eur Urol 51 2007 1469 1471
123. A.A. Renshaw UroVysion, urine cytology, and the College of American Pathologists: where should we go from here? Arch Pathol Lab Med 134 2010 1106 1107
124. Amin MB, Delahunt B, Bochner BH, et al. Protocol for the examination of specimens from patients with carcinoma of the urinary bladder. In: Reporting on cancer specimens. Case summaries and background documentation. Northfield, IL: College of American Pathologists Press; 2009.